Nurse Practitioner · Fort Wayne, IN
NPI
1891098745
Since 2010
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2231 Carew St
Fort Wayne, IN, 46805
Phone (260) 373-9935
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
263 services
Medicare patients, 2024
91
Average age 72
Drug cost, 2024
$3.0M
1,049 prescriptions
Company payments, 2025
$399
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew C Barchus was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 72 times for 34 patients. In total Andrew C Barchus billed 263 services in 10 codes, and Medicare paid $14K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 72 | 34 | $9.73 | $701 |
| 99214 Office E&M - Established | Facility | 68 | 44 | $58.68 | $3,990 |
| 99215 Office E&M - Established | Facility | 68 | 48 | $88.28 | $6,003 |
By year: 2022 $13K for 196 services; 2023 $11K for 168 services; 2024 $14K for 263 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew C Barchus prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 226 prescriptions and refills. In total Andrew C Barchus wrote 1,049 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 226 | 226 | 24 | $864K |
| Dovato Dolutegravir Sodium/Lamivudine | 130 | 130 | 14 | $381K |
| Cephalexin Generic | 68 | 127 | 25 | $1,845 |
| Vemlidy Tenofovir Alafenamide | 55 | 55 | Under 11 | $83K |
| Epclusa Sofosbuvir/Velpatasvir | 36 | 36 | 15 | $842K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 34 | 38 | 11 | $755 |
| Cefadroxil Generic | 29 | 41 | 11 | $1,654 |
| Descovy Emtricitabine/Tenofov Alafenam | 25 | 25 | Under 11 | $55K |
| Tivicay Dolutegravir Sodium | 25 | 25 | Under 11 | $81K |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 23 | 23 | Under 11 | $184K |
| Cabenuva Cabotegravir/Rilpivirine | 23 | 43 | Under 11 | $150K |
| Doxycycline Hyclate Generic | 22 | 30 | 14 | $359 |
| Juluca Dolutegravir/Rilpivirine | 21 | 21 | Under 11 | $73K |
| Levofloxacin Generic | 21 | 21 | Under 11 | $192 |
| Fluconazole Generic | 19 | 19 | Under 11 | $466 |
Brand drugs: 639 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew C Barchus $399 ($399 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $358.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 13 | $358 |
| Melinta Therapeutics, LLC | 1 | $26.86 |
| Ferring Pharmaceuticals Inc. | 1 | $14.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.